drugset / Trial / NCT06194565
99mTc-ABH2 SPECT/CT in Breast Cancer
NaSingle-groupOpen-labelDiagnostic
Summary
This prospective study will investigate the potential usefulness of 99mTc-ABH2 SPECT/CT in the diagnostic performance and evaluation efficacy of breast cancer.
Timeline
- Start
- 2023-03-20
- Primary completion
- 2023-12-30
- Completion
- 2024-01-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 99mTc-ABH2 | Diagnostic / imaging agent | 5.55 mbq/kg | Intravenous |
| Subject | 99mTc-ABH2 | Diagnostic / imaging agent | 7.4 mbq/kg | Intravenous |